At the time of writing, CASI Pharmaceuticals Inc [CASI] stock is trading at $1.95, up 51.16%. An important factor to consider is whether the stock is rising or falling in short-term value. The CASI shares have gain 20.37% over the last week, with a monthly amount glided 50.00%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CASI Pharmaceuticals Inc [NASDAQ: CASI] stock has seen the most recent analyst activity on May 18, 2021, when BTIG Research initiated its Buy rating and assigned the stock a price target of $4. Previously, Mizuho started tracking the stock with Buy rating on April 26, 2021, and set its price target to $3.80. On October 23, 2020, Oppenheimer initiated with a Outperform rating and assigned a price target of $5 on the stock. Maxim Group started tracking the stock assigning a Buy rating and suggested a price target of $4 on September 22, 2016. H.C. Wainwright started tracking with a Buy rating for this stock on June 23, 2015, and assigned it a price target of $2.50.
For the past year, the stock price of CASI Pharmaceuticals Inc fluctuated between $1.09 and $7.67. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. CASI Pharmaceuticals Inc [NASDAQ: CASI] shares were valued at $1.95 at the most recent close of the market. An investor can expect a potential return of 207.69% based on the average CASI price forecast.
Analyzing the CASI fundamentals
According to CASI Pharmaceuticals Inc [NASDAQ:CASI], the company’s sales were 31.37M for trailing twelve months, which represents an 83.04% jump. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -1.29%, Pretax Profit Margin comes in at -1.25%, and Net Profit Margin reading is -1.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -9.73 and Total Capital is -5.7. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that CASI Pharmaceuticals Inc [NASDAQ:CASI] has a current ratio of 0.81. On the other hand, the Quick Ratio is 0.68, and the Cash Ratio is 0.32. Considering the valuation of this stock, the price to sales ratio is 0.96.
